Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

508

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

January 31, 2008

Conditions
Major Depressive Disorder
Interventions
DRUG

agomelatine

DRUG

placebo

Trial Locations (44)

10021

Novartis Investigative Site, New York

11235

Novartis Investigative Site, Brooklyn

20852

Novartis Investigative Site, Rockville

21801

Novartis Investigative Site, Salisbury

23112

Novartis Investigative Site, Midlothian

29406

Novartis Investigative Site, North Charleston

30060

Novartis Investigative Site, Marietta

30308

Novartis Investigative Site, Atlanta

30329

Novartis Investigative Site, Atlanta

32216

Novartis Investigative Site, Jacksonville

32751

Novartis Investigative Site, Maitland

33952

Novartis Investigative Site, Port Charlotte

34208

Novartis Investigative Site, Bradenton

37203

Novartis Investigative Site, Nashville

44122

Novartis Investigative Site, Beachwood

45408

Novartis Investigative Site, Dayton

48307

Novartis Investigative Site, Rochester Hills

48336

Novartis Investigative Site, Farmington Hills

63376

Novartis Investigative Site, City of Saint Peters

66212

Novartis Investigative Site, Overland Park

72205

Novartis Investigative Site, Little Rock

74136

Novartis Investigative Site, Tulsa

75231

Novartis Investigative Site, Dallas

77007

Novartis Investigative Site, Houston

78754

Novartis Investigative Site, Austin

84107

Novartis Investigative Site, Salt Lake City

85251

Novartis Investigative Site, Scottsdale

87102

Novartis Investigative Site, Albuquerque

90703

Novartis Investigative Site, Cerritos

92126

Novartis Investigative Site, San Diego

92243

Novartis Investigative Site, El Centro

92591

Novartis Investigative Site, Temecula

92618

Novartis Investigative Site, Irvine

92845

Novartis Investigative Site, Garden Grove

94549

Novartis Investigative Site, Lafayette

97404

Novartis Investigative Site, Eugene

98011

Novartis Investigative Site, Bothell

06416

Novartis Investigative Site, Cromwell

06518

Novartis Investigative Site, Hamden

01201

Novartis Investigative Site, Pittsfield

08540

Novartis Investigative Site, Princeton

05201

Novartis Investigative Site, Bennington

00959

Novartis Investigative Site, Bayamón

Unknown

Novartis Investigative Site, Rio Piedras

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY